Dosing of Antimycotic Treatment in Sepsis-Induced Liver Dysfunction by Functional Liver Testing with LiMAx
Publicat a: | Case Reports in Critical Care (2019)5362514, S. 6 |
---|---|
Autors principals: | Kirchner, Carmen (Autor), Sibai, Jasmin (Autor), Schwier, Elke (Autor), Henzler, Dietrich (Autor), Eickmeyer, Claas (Autor), Winde, Günther (Autor), Köhler, Thomas (Autor) |
Format: | Article |
Idioma: | English |
Publicat: |
2019
|
Matèries: | |
Accés en línia: | https://doi.org/10.1155/2019/5362514 |
Publicació relacionada: | In:
Case Reports in Critical Care |
Ítems similars
-
Profound decrease of liver maximum function capacity test of isoflurane sedated patients : a report of three cases
per: Schwier, Elke, et al.
Publicat: (2021) -
The impact of the COVID-19 pandemic on non-COVID induced sepsis survival
per: Unterberg, Matthias, et al.
Publicat: (2022) -
Pericarditis caused by Enterococcus faecium with acute liver failure treated by a multifaceted approach including antimicrobials and hemoadsorption
per: Köhler, Thomas, et al.
Publicat: (2021) -
Immunomodulation by Hemoadsorption-Changes in Hepatic Biotransformation Capacity in Sepsis and Septic Shock : a prospective study.
per: Praxenthaler, Janina, et al.
Publicat: (2022) -
Treatment of intraoperative hypotension with cafedrine/theodrenaline versus ephedrine : A prospective, national, multicenter, non-interventional study-the HYPOTENS trial.
per: Eberhart, L., et al.
Publicat: (2021)